CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Unifi Wealth Management buys stake in Majesco
Ganesh V
/ Categories: Trending, DSIJ News

Unifi Wealth Management buys stake in Majesco

Unifi Wealth has bought 2.06 lakh equity shares of Majesco at Rs 779.05 per share.

At 2.47 pm, the share of Majesco was trading at Rs 811.60 on BSE, up by 4.31 per cent. The stock has recovered by 357.51 per cent from its sharp decline of March 2020 and today, made a new 52-week high of Rs 816.

The net profit of Majesco fell by 4.8 per cent to Rs 11.44 crore in Q1FY21 as against Rs 12.02 crore during Q1FY20. Its sales rose 20.09 per cent to Rs 311 crore in Q1FY21 as against Rs 258.98 crore during Q1FY20.

Majesco provides leadership, technology, and expertise that help insurers innovate, modernise, and connect to build the future of their business as well as of insurance at speed and scale.

It has given returns of 123.73 per cent, 244.02 per cent, and 94.01 per cent for 3 months, 6 months, and 1 year, respectively. According to BSE data, the stock traded at a P/E multiple of 212.21 and a price-to-book ratio of 3.98.

Previous Article Is Repo rate linked housing loan, a deal-breaker?
Next Article Sun Pharma launches ILUMYA for treatment of plaque psoriasis in Japan
Print
1293 Rate this article:
4.2
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR